Clinical trials: Sinus Endoscopic Surgery

Ethmoid Sinusitis, Rhinosinusitis

Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel

• Completed
• Age: 18 to 85 years
• Phase 4
• Injection or infusion
• Medical device
• Results posted

The purpose of this study is to evaluate the safety and effectiveness of AdvaCoat® sinus gel, a nasal/sinus dressing, for adhesion prevention following endoscopic ethmoid sinus surgery.

Trial name

NCT00554190

Testing

AdvaCoat sinus gel, Merogel Injectable

Where

4 sites in United States

Volunteers

29 people

Sponsor

Carbylan Therapeutics, Inc.